Zimmer Biomet Holdings Additions To Instruments increased by 3.9% to $77.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 29.3%, from $59.70M to $77.20M. Over 4 years (FY 2021 to FY 2025), Additions To Instruments shows relatively stable performance with a 2.4% CAGR.
Higher spending indicates investment in market expansion or new product launches, while lower spending may suggest a mature product cycle or cost-cutting.
This represents capital expenditures specifically related to surgical instruments and loaner sets used by surgeons. Thes...
Specific to the orthopedic and surgical device industry; peers also report high levels of instrument-related capital expenditure.
investing_additions_to_instruments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $61.10M | $69.70M | $70.60M | $56.40M | $64.20M | $71.60M | $66.10M | $82.80M | $85.50M | $64.50M | $78.90M | $82.00M | $65.20M | $41.20M | $51.90M | $59.70M | $80.50M | $86.00M | $74.30M | $77.20M |
| QoQ Change | — | +14.1% | +1.3% | -20.1% | +13.8% | +11.5% | -7.7% | +25.3% | +3.3% | -24.6% | +22.3% | +3.9% | -20.5% | -36.8% | +26.0% | +15.0% | +34.8% | +6.8% | -13.6% | +3.9% |
| YoY Change | — | — | — | — | +5.1% | +2.7% | -6.4% | +46.8% | +33.2% | -9.9% | +19.4% | -1.0% | -23.7% | -36.1% | -34.2% | -27.2% | +23.5% | +108.7% | +43.2% | +29.3% |